| Asset | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Equity | 98.91% | 95.01% | 97.16% | 96.05% | 99.82% | 96.76% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | 1.09% | 4.99% | 2.84% | 3.95% | 0.18% | 3.24% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 43,38,091 | 788.06 | 11.49% | -0.82%↓ |
| Dr. Reddys Laboratories Ltd. | Healthcare | 54,14,201 | 667.57 | 9.73% | 1.47%↑ |
| Cipla Ltd. | Healthcare | 29,49,351 | 396.98 | 5.79% | 0.03%↑ |
| Biocon Ltd. | Healthcare | 98,76,830 | 365.74 | 5.33% | 0.65%↑ |
| Mankind Pharma Ltd. | Healthcare | 13,82,093 | 346.05 | 5.04% | -0.17%↓ |
| Alkem Laboratories Ltd. | Healthcare | 6,39,791 | 330.36 | 4.81% | -0.06%↓ |
| Medplus Health Services Ltd. | Healthcare | 45,14,490 | 295.65 | 4.31% | 0.16%↑ |
| Cohance Lifesciences Ltd. | Healthcare | 62,66,692 | 278.24 | 4.06% | -0.03%↓ |
| Divis Laboratories Ltd. | Healthcare | 2,79,019 | 259.25 | 3.78% | -1.05%↓ |
| Syngene International Ltd. | Healthcare | 65,78,033 | 240.3 | 3.50% | 0.21%↑ |
| Dr. Agarwals Health Care Ltd. | Healthcare | 38,05,624 | 182.4 | 2.66% | -0.13%↓ |
| Max Healthcare Institute Ltd. | Healthcare | 19,41,433 | 180.51 | 2.63% | 0.04%↑ |
| Abbott India Ltd. | Healthcare | 64,361 | 174.58 | 2.54% | 0.17%↑ |
| Alembic Pharmaceuticals Ltd. | Healthcare | 20,77,449 | 171.48 | 2.50% | 0.02%↑ |
| Pfizer Ltd. | Healthcare | 4,29,173 | 166.32 | 2.42% | 0.57%↑ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 1,93,516 | 158.02 | 2.30% | - |
| Gland Pharma Ltd. | Healthcare | 4,65,318 | 134.91 | 1.97% | - |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 16,04,863 | 131.36 | 1.91% | -0.08%↓ |
| Lupin Ltd. | Healthcare | 6,36,370 | 129.2 | 1.88% | -0.08%↓ |
| Astrazeneca Pharma India Ltd. | Healthcare | 2,04,986 | 126.8 | 1.85% | -0.14%↓ |
| Sector | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 96.64% | 92.66% | 94.71% | 93.39% | 97.25% | 94.36% |
| Chemicals | 1.21% | 1.22% | 1.18% | 1.33% | 1.19% | 1.15% |
| Services | 1.06% | 1.13% | 1.27% | 1.33% | 1.38% | 1.25% |
38.4 / 100
Weighted average Value score is 38.4. This indicates that portfolio is relatively reasonably valued using composite of value measures.
70.2 / 100
Weighted average Price Momentum score is 70.2. This indicates that portfolio has average momentum using composite of momentum measures.
80.0 / 100
Weighted average Quality score is 80.0. This indicates that portfolio has high quality using composite of quality measures.
74.5 / 100
Weighted average QVM score is 74.5. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
